Amicus Therapeutics
FOLD
#3908
Rank
C$4.21 B
Marketcap
C$13.68
Share price
-0.50%
Change (1 day)
-0.06%
Change (1 year)

Amicus Therapeutics (FOLD) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.61 Billion

According to Amicus Therapeutics 's latest financial reports the company's total debt is C$0.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Amicus Therapeutics - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.63 B7.85%
2023-12-31C$0.59 B-3.78%
2022-12-31C$0.61 B9.38%
2021-12-31C$0.56 B-0.41%
2020-12-31C$0.56 B105.14%
2019-12-31C$0.27 B-37.35%
2018-12-31C$0.43 B112.34%
2017-12-31C$0.20 B-0.75%
2016-12-31C$0.20 B260.35%
2015-12-31C$57.7 M246.54%
2014-12-31C$16.65 M8.09%
2013-12-31C$15.4 M2122.85%
2012-12-31C$0.69 M-34.73%
2011-12-31C$1.06 M-54.54%
2010-12-31C$2.33 M-43.1%
2009-12-31C$4.1 M182.8%
2008-12-31C$1.45 M-46.52%
2007-12-31C$2.71 M-34.57%
2006-12-31C$4.14 M251.52%
2005-12-31C$1.18 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
C$9.10 B 1,388.21%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.83 B 36.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.42 B-30.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$32.96 B 5,288.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
C$80.33 M-86.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$21.98 B 3,494.07%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark